Nexplanon Complications â A Complete Patient Guide
Overview
Nexplanon (brand name for the etonogestrelâreleasing subdermal implant) is a thin, flexible, 4âcm rod inserted just under the skin of the upper arm. It releases a low, steady dose of the progestin hormone etonogestrel and provides up to three years of highly effective contraception (failure rate < 1%).
- Who uses it? Over 1âŻmillion women worldwide have used Nexplanon since its FDA approval in 2011, with the highest uptake among women aged 18â35 who want a âsetâandâforgetâ method.
- Prevalence of complications â Most users experience no serious problems. Reported adverse events range from mild (skin irritation) to rare but serious (vascular injury, implant migration). Systematic reviews estimate that 1â2âŻ% of users develop clinically significant complications that require medical attention.
Symptoms
Complications can manifest in many ways. Below is a comprehensive list of symptoms you may notice, grouped by the system involved.
Local (at the insertion site)
- Pain or tenderness â persistent throbbing, sharp stabbing, or ache that lasts >âŻ48âŻh.
- Swelling, bruising, or lump â may indicate hematoma, infection, or implant migration.
- Redness or warmth â signs of cellulitis or an early abscess.
- Numbness or tingling â suggests nerve irritation or compression.
- Visible or palpable implant migration â the rod feels higher or lower than the original insertion point.
Systemic (throughout the body)
- Irregular bleeding â prolonged spotting, heavy periods, or complete amenorrhea.
- Headache, migraine, or visual disturbances â can be hormoneârelated or a sign of vascular complication.
- Breast tenderness or enlargement.
- Weight gain or loss â beyond normal fluctuations.
- Acne or skin changes.
- Depressed mood, anxiety, or irritability.
- Leg swelling, calf pain, or shortness of breath â rare but may signal a blood clot (deepâvein thrombosis or pulmonary embolism).
Rare but serious symptoms
- Sudden severe abdominal pain.
- High fever (>âŻ38.5âŻÂ°C / 101.3âŻÂ°F) with chills.
- Rapid heart rate (>âŻ120âŻbpm) or low blood pressure.
- Neurologic deficits (weakness, vision loss) suggestive of embolic events.
Causes and Risk Factors
Complications arise from three main mechanisms: insertion/ removal technique, the bodyâs response to the hormone, and rare mechanical problems.
Insertionârelated causes
- Improper placement â too deep, too superficial, or within a blood vessel.
- Trauma to surrounding structures â damage to the biceps brachii, median nerve, or brachial artery.
- Infection â introduced at the time of insertion if sterile technique is insufficient.
Hormoneârelated causes
- Systemic side effects of etonogestrel (similar to other progestinâonly methods).
- Individual sensitivity to progestins â higher rates of mood changes, weight fluctuation, or acne.
Mechanical issues
- Implant migration â rare (â0.1âŻ%); the rod can move from the arm into deeper tissue, sometimes even to the chest wall.
- Breakage or fragmentation â usually occurs during removal; small pieces can remain embedded.
Risk factors that increase the likelihood of complications
- Obesity (BMIâŻâ„âŻ30) â makes accurate placement more difficult.
- History of scar tissue or prior arm surgery.
- Coagulopathy or use of anticoagulant medication â higher risk of hematoma.
- Smoking (especially >âŻ10 cigarettes/day) â raises risk of thromboembolic events.
- Pregnancy at the time of insertion or undiagnosed pregnancy â can affect hormone metabolism.
- Inexperienced provider â studies show higher complication rates when the inserter has performed <âŻ10 procedures.
Diagnosis
Diagnosing Nexplanon complications involves a combination of history, physical examination, and targeted investigations.
Clinical evaluation
- Detailed symptom timeline (onset, severity, aggravating factors).
- Inspection and palpation of the arm to locate the implant.
- Assessment for signs of infection (fever, erythema) or neurovascular compromise.
Imaging studies
- Ultrasound â firstâline for locating a nonâpalpable implant, detecting hematoma or abscess.
- Plain radiography â the implant contains radiopaque barium sulfate; Xâray can confirm migration.
- Computed tomography (CT) or MRI â reserved for deep or atypical migration, especially when the rod is suspected to be near vital structures.
Laboratory tests
- Complete blood count (CBC) â to evaluate infection or anemia from heavy bleeding.
- Coagulation profile (PT/INR, aPTT) â if clotting disorder is suspected.
- Blood cultures â only if systemic infection is suspected.
- Hormone levels (serum etonogestrel) â rarely needed, but can be measured in research settings.
Specialist evaluation
Referral to a dermatologist, vascular surgeon, or a reproductive endocrinologist may be required based on the presenting problem.
Treatment Options
The therapeutic plan depends on the type and severity of the complication.
Local complications
- Minor pain or bruising â Ice, overâtheâcounter NSAIDs (ibuprofen 200â400âŻmg q6â8âŻh), and arm elevation for 48âŻh.
- Infection (cellulitis or abscess) â Oral antibiotics (e.g., clindamycin 300âŻmg q6âŻh) for 7â10âŻdays; incision & drainage if an abscess forms.
- Implant migration â Surgical removal under local or general anesthesia, guided by ultrasound or fluoroscopy.
- Nerve irritation â Prompt removal of the implant, followed by physical therapy if residual numbness persists.
Systemic hormoneârelated effects
- Irregular bleeding â NSAIDs for breakthrough bleeding, tranexamic acid (1âŻg q8âŻh) for heavy periods, or temporary use of combined oral contraceptive pills.
- Mood or weight changes â Lifestyle counseling; if severe, discuss alternative contraception.
Thromboembolic complications
- Immediate cessation of progestin exposure (remove Nexplanon).
- Anticoagulation therapy per ACCP guidelines (e.g., lowâmolecularâweight heparin â warfarin or a direct oral anticoagulant).
- Hospital admission for monitoring if pulmonary embolism is suspected.
Removal techniques
- Standard removal â A small incision (â5âŻmm) is made over the palpable implant; the rod is extracted with a specialized removal device.
- Ultrasoundâguided removal â Used when the implant is nonâpalpable or deep; realâtime imaging directs the incision.
- Surgical excision â Rare; required when the implant has fragmented or is encased in scar tissue.
Alternative contraception after complications
- Intrauterine device (copper or LNGâIUS).
- Combination oral contraceptives.
- Barrier methods (condoms, diaphragm) with spermicide.
- Other longâacting reversible contraception (LARC) such as the hormonal IUD.
Living with Nexplanon Complications
Even after treatment, many women need ongoing strategies to manage lingering effects.
- Track menstrual changes â Use a periodâtracking app for at least three cycles to spot patterns.
- Skin care â Keep the insertion site clean; apply topical antibiotic ointment if minor irritation persists.
- Pain management â Rotate NSAIDs with acetaminophen; avoid chronic highâdose NSAIDs without physician guidance.
- Physical activity â Gentle arm stretches and strengthening exercises can improve circulation and reduce nerve irritation.
- Mental health â If mood changes occur, consider counseling, stressâreduction techniques, or a referral to a mentalâhealth professional.
- Followâup appointments â Schedule a visit 2â4âŻweeks after removal to ensure proper wound healing and to discuss future contraception.
Prevention
Many complications are avoidable with proper technique and patient education.
- Choose an experienced provider â Seek clinicians who have inserted â„âŻ20 Nexplanon devices.
- Preâinsertion screening â Review medical history for clotting disorders, pregnancy, infection, or skin conditions.
- Aseptic technique â Use sterile gloves, skin antiseptic, and a dedicated insertion kit.
- Correct placement â The needle should be inserted at a 30â45° angle over the inner side of the nonâdominant upper arm, 6â8âŻcm distal to the acromion.
- Patient education â Teach the user how to feel for the implant tip and when to call if they notice migration or swelling.
- Regular selfâchecks â Monthly palpation of the implant; report any change in feel.
- Smoking cessation â Reduces thrombotic risk.
Complications of Untreated Issues
If a complication is ignored, it can lead to more serious health problems.
- Undiagnosed infection â May progress to cellulitis, abscess, or systemic sepsis.
- Implant migration â Can involve the thoracic cavity, leading to chest pain, pneumothorax, or damage to major vessels.
- Chronic pain or nerve damage â May become permanent, limiting arm function.
- Severe menstrual disturbances â Result in anemia, fatigue, and decreased quality of life.
- Thromboembolic events â Untreated deepâvein thrombosis can cause pulmonary embolism, which is lifeâthreatening.
When to Seek Emergency Care
- Rapidly spreading redness, swelling, or severe pain at the insertion site together with fever >âŻ38.5âŻÂ°C (101.3âŻÂ°F).
- Sudden shortness of breath, chest pain, or coughing up blood.
- Severe, unrelenting headache or visual changes.
- Sudden leg swelling, calf pain, or a feeling of heaviness in the leg.
- Rapid heartbeat (>âŻ120 beats/min) or a drop in blood pressure causing dizziness or fainting.
- Loss of sensation or strength in the arm, hand, or fingers.
These symptoms may signal infection, vascular injury, or a blood clotâconditions that require immediate medical attention.
References
- Mayo Clinic. âNexplanon (Implant) â Risks and Side Effects.â mayoclinic.org (accessed MayâŻ2026).
- Centers for Disease Control and Prevention. âLongâActing Reversible Contraception (LARC).â cdc.gov.
- World Health Organization. âMedical Eligibility Criteria for Contraceptive Use.â 2023 update.
- Cleveland Clinic. âImplantable Contraceptives: What to Expect.â clevelandclinic.org.
- American College of Obstetricians and Gynecologists. Practice Bulletin No.âŻ205: LongâActing Reversible Contraception. 2022.
- Heinemann K, etâŻal. âComplications of the etonogestrel subâdermal implant: a systematic review.â *Contraception*, 2021;104(5): 331â339.
- Arora S, etâŻal. âImplant migration after Nexplanon insertion: case series and literature review.â *Obstetrics & Gynecology*, 2020;136(2): 235â242.